Literature DB >> 16826448

Recurrent infections and immunological dysfunction in congenital disorder of glycosylation Ia (CDG Ia).

C Blank1, L A Smith, D A Hammer, M Fehrenbach, H M Delisser, E Perez, K E Sullivan.   

Abstract

Congenital disorder of glycosylation Ia is the most common defect of glycosylation and is due to mutations in phosphomannomutase 2. This leads to aberrant N-linked oligosaccharides. The phenotype of CDG Ia reflects the essential nature of glycosylation and patients typically present with multiple organs affected, with hypotonia, developmental delay, inverted nipples and abnormal fat pads. Later features include retinitis pigmentosa, stroke, cerebellar atrophy and malabsorption. Approximately 20% of patients die in the first year of life and infection is the most common cause of death. Immunological function has not previously been investigated in these patients and the critical role of oligosaccharides on adhesion molecules suggested that haematopoietic cell migration and communication could be disrupted by mutations in phosphomannomutase 2. We characterized the clinical features, performed standard immunological evaluations, and performed specific analyses of neutrophil adhesion molecules on two patients to address this question. Patient neutrophils had diminished chemotaxis but expressed comparable levels of adhesion molecules and rolled on artificial endothelium equivalently to control neutrophils. The most significant feature of the patients' immunological function was poor vaccine responses. These two affected patients were begun on intravenous immunoglobulin with some improvement in their infections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16826448     DOI: 10.1007/s10545-006-0275-2

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  9 in total

1.  Deficiency of Subunit 6 of the Conserved Oligomeric Golgi Complex (COG6-CDG): Second Patient, Different Phenotype.

Authors:  S Huybrechts; C De Laet; P Bontems; S Rooze; H Souayah; Y Sznajer; L Sturiale; D Garozzo; G Matthijs; A Ferster; J Jaeken; P Goyens
Journal:  JIMD Rep       Date:  2011-11-02

2.  Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation.

Authors:  Paola de Haas; Marien I de Jonge; Hans J P M Koenen; Ben Joosten; Mirian C H Janssen; Lonneke de Boer; Wiljan J A J Hendriks; Dirk J Lefeber; Alessandra Cambi
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  N-glycosylation deficiency reduces ICAM-1 induction and impairs inflammatory response.

Authors:  Ping He; Geetha Srikrishna; Hudson H Freeze
Journal:  Glycobiology       Date:  2014-01-28       Impact factor: 4.313

Review 4.  Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update.

Authors:  Jan Verheijen; Shawn Tahata; Tamas Kozicz; Peter Witters; Eva Morava
Journal:  Genet Med       Date:  2019-09-19       Impact factor: 8.822

Review 5.  Immunological aspects of congenital disorders of glycosylation (CDG): a review.

Authors:  Maria Monticelli; Tiago Ferro; Jaak Jaeken; Vanessa Dos Reis Ferreira; Paula A Videira
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.750

Review 6.  Glycans Instructing Immunity: The Emerging Role of Altered Glycosylation in Clinical Immunology.

Authors:  Jonathan J Lyons; Joshua D Milner; Sergio D Rosenzweig
Journal:  Front Pediatr       Date:  2015-06-11       Impact factor: 3.418

7.  Natural Killer Cell Receptors and Cytotoxic Activity in Phosphomannomutase 2 Deficiency (PMM2-CDG).

Authors:  Roberto García-López; María Eugenia de la Morena-Barrio; Laia Alsina; Belén Pérez-Dueñas; Jaak Jaeken; Mercedes Serrano; Mercedes Casado; Trinidad Hernández-Caselles
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

8.  High N-glycan multiplicity is critical for neuronal adhesion and sensitizes the developing cerebellum to N-glycosylation defect.

Authors:  Daniel Medina-Cano; Ekin Ucuncu; Lam Son Nguyen; Michael Nicouleau; Joanna Lipecka; Jean-Charles Bizot; Christian Thiel; François Foulquier; Nathalie Lefort; Catherine Faivre-Sarrailh; Laurence Colleaux; Ida Chiara Guerrera; Vincent Cantagrel
Journal:  Elife       Date:  2018-10-12       Impact factor: 8.140

9.  GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients.

Authors:  Maria E de la Morena-Barrio; Trinidad Hernández-Caselles; Javier Corral; Roberto García-López; Irene Martínez-Martínez; Belen Pérez-Dueñas; Carmen Altisent; Teresa Sevivas; Soren R Kristensen; Encarna Guillén-Navarro; Antonia Miñano; Vicente Vicente; Jaak Jaeken; Maria L Lozano
Journal:  Orphanet J Rare Dis       Date:  2013-10-20       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.